← The Wire
ATRCNasdaq
AtriCure, Inc.
Surgical & Medical Instruments & Apparatus · DE · CIK 1323885
AtriCure innovates surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain relief
red 8-K · 90d
$1.46B
Market cap
$28.70
Last close
-4.9%
1D
+0.9%
5D
2.0M
Volume
Price · last 39 sessions-0.3%
May 4L $25.86 · H $30.18Jun 29
240
Total filings
May 19, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 19, 202610-Q10-QMay 6, 20268-K/AResults of OperationsMay 6, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 6, 2026DEF 14ADEF 14AApr 6, 202610-K10-KFeb 19, 20268-KResults of OperationsFeb 17, 20268-KMaterial Agreement · Results of OperationsJan 12, 202610-Q10-QOct 30, 20258-K/AResults of OperationsOct 29, 20258-KResults of OperationsOct 29, 202510-Q10-QJul 30, 20258-KResults of OperationsJul 29, 20258-KExecutive Change · Shareholder VoteMay 20, 2025DEFA14ADEFA14AMay 5, 202510-Q10-QApr 30, 20258-KResults of OperationsApr 29, 2025DEFA14ADEFA14AApr 7, 2025DEF 14ADEF 14AApr 7, 20258-KReg FD DisclosureMar 26, 202510-K10-KFeb 14, 20258-KResults of OperationsFeb 12, 20258-KResults of Operations · Reg FD DisclosureJan 13, 2025SC 13GSC 13GNov 14, 202410-Q10-QOct 30, 20248-KResults of OperationsOct 29, 202410-Q10-QJul 31, 20248-KResults of OperationsJul 30, 20248-KExecutive Change · Bylaw AmendmentMay 14, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 1, 2024DEFA14ADEFA14AApr 23, 2024DEFA14ADEFA14AApr 23, 2024DEFA14ADEFA14AApr 3, 2024DEF 14ADEF 14AApr 3, 20248-K/AExecutive ChangeFeb 27, 202410-K10-KFeb 16, 20248-KResults of OperationsFeb 15, 20248-KMaterial Agreement · Agreement TerminatedJan 8, 20248-KExecutive ChangeJan 4, 202410-Q10-QNov 2, 20238-KResults of OperationsNov 1, 202310-Q10-QJul 26, 20238-KResults of OperationsJul 25, 20238-KExecutive Change · Shareholder VoteMay 26, 202310-Q10-QMay 3, 20238-KResults of OperationsMay 2, 2023DEFA14ADEFA14AApr 10, 2023DEF 14ADEF 14AApr 10, 202310-K10-KFeb 22, 20238-KResults of OperationsFeb 21, 20238-KResults of Operations · Reg FD DisclosureJan 9, 202310-Q10-QNov 2, 20228-KResults of OperationsNov 1, 202210-Q10-QAug 3, 20228-KResults of Operations · Reg FD DisclosureAug 2, 20228-KExecutive Change · Shareholder VoteMay 27, 202210-Q10-QMay 4, 20228-KResults of Operations · Reg FD DisclosureMay 3, 20228-KReg FD DisclosureApr 13, 2022DEFA14ADEFA14AApr 11, 2022DEF 14ADEF 14AApr 11, 202210-K10-KFeb 17, 20228-KResults of OperationsFeb 15, 2022SC 13GSC 13GFeb 14, 20228-KResults of Operations · Reg FD DisclosureJan 10, 202210-Q10-QNov 4, 20218-KResults of OperationsNov 3, 202110-Q10-QAug 5, 20218-KResults of Operations · Reg FD DisclosureAug 4, 20218-KExecutive ChangeJun 15, 20218-KShareholder VoteMay 24, 20218-KReg FD DisclosureApr 29, 202110-Q10-QApr 28, 20218-KResults of OperationsApr 27, 2021DEFA14ADEFA14AApr 8, 2021DEF 14ADEF 14AApr 8, 20218-KExecutive ChangeApr 8, 202110-K10-KFeb 26, 2021
Insider Activity
In the 90 days to Mar 12, 2026: 1 sold $149K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Doraiswamy VinayakChief Scientific Officer | Sell | 5,000 | $29.83 | $149K |
| Nov 26, 2025 | Noznesky Justin JChief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $193K |
| Nov 25, 2025 | Wehrwein SvenDirector | Sell | 4,967 | $38.00 | $189K |
| Nov 24, 2025 | Wehrwein SvenDirector | Sell | 5,033 | $37.32 | $188K |
| Nov 21, 2025 | Yuen MaggieDirector | Sell | 3,000 | $35.72 | $107K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance